Related to this topic: Patient+ | Medicines | Equipment | Books | Your Experience | Other resources | Glossaries
Print options:
Other options:
(what's this?)
PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.
Anti-androgens: Cyproterone Acetate, Dutasteride, Finasteride
This includes:
- Cyproterone acetate - an anti androgen.
- Dutasteride and finasteride inhibit the enzyme 5α-reductase, which converts testosterone into dihydrotestosterone which is more potent.
Indications
- Cyproterone acetate inhibits spermatogenesis leading to reversible infertility (but not a male contraceptive)
- Severe hypersexuality in men i.e. increased libido as in de Clerembaults'
- Sexual deviation in men
- Prostate cancer2
- Treatment of acne and hirsutism in women3
It is advised to obtain informed consent prior to starting therapy with cyproterone acetate and a spermatogram.
Cautions
- If chronic alcoholism present then may be ineffective for male hypersexuality
- Monitor full blood counts at beginning and every 2 - 3 of months whilst treatment continues
- Monitor liver function tests regularly (same frequency as blood counts)
- Monitor adrenocortical function e.g. monitor for hyponatraemia and hyperkalaemia and perform 9am cortisol if suspicious
- May impair performance of skilled tasks
Contraindications
- Hepatic impairment
- Diabetes mellitus with vascular complications
- Sickle-cell anaemia
- Malignant disease
- Severe depression
- Thrombo-embolic disease
Adverse effects1
- Fatigue
- Weight gain
- Breathlessness
- Gynaecomastia
- Hypersensitivity
- Skin rashes
- Osteoporosis
- Bone maturation and testicular development are inhibited when used in those under 18 years
- Hepatic impairment and failure
Animal studies have linked cyproterone acetate with hepatic tumours, thus weigh up all risks and benefits before initiating treatment.
Indications
- Benign prostatic hypertrophy (BPH) - leads to reduction in prostatic size, improving urinary outflow. Alternatives to α blockers. Finasteride can be used with doxazosin in BPH.6
- Male pattern baldness in men - low dose finasteride has been used.
Cautions
- Reduce prostatic specific antigen thus not accurate in prostatic cancer
- Use of condom advised as they are excreted in semen and may be absorbed by pregnant females or females of child-bearing potential affecting an unborn male child
Contraindications
- Women (avoid handling broken tablets and capsules if of child-bearing potential), children and adolescents.
Adverse effects
- Reduced libido
- Sexual dysfunction; including impotence and impaired ejaculation
- Breast enlargement and pain
- Testicular pain
- Hypersensitivity reactions
Cyproterone acetate
- Has been associated with hepatic tumours in animals. In humans it is associated with jaundice, hepatitis and hepatic failure.7
- Therefore need regular monitoring of LFTs.
- Also monitor blood glucose in diabetic patients.
- Not for use in patients under 18 years - may delay bone and testicular development.
Dutasteride and finasteride
- Is excreted in semen and condom use recommended if sexual partner pregnant or likely to become pregnant.
- May take 6 months or longer for benefit.
Document references
- Specific Product Characteristics (SPC) Cyproterone acetate®;; Bayer plc; May 2008.
- Anderson J; The role of antiandrogen monotherapy in the treatment of prostate cancer. BJU Int. 2003 Mar;91(5):455-61. [abstract]
- Van der Spuy ZM, le Roux PA; Cyproterone acetate for hirsutism. Cochrane Database Syst Rev. 2003;(4):CD001125. [abstract]
- Specific Product Characteristics (SPC) Dutasteride®; GlaxoSmithKline UK; May 2008.
- Specific Product Characteristics (SPC) Finasteride®; Merck Sharp & Dohme Limited; Mar 2008.
- Kuritzky L; Noninvasive management of lower urinary tract symptoms and sexual dysfunction associated with benign prostatic hyperplasia in the primary care setting. Compr Ther. 2005 Fall;31(3):194-208. [abstract]
- Thole Z, Manso G, Salgueiro E, et al; Hepatotoxicity induced by antiandrogens: a review of the literature. Urol Int. 2004;73(4):289-95. [abstract]
DocID: 255
Document Version: 2
DocRef: bgp25172
Last Updated: 29 Jul 2008
Review Date: 29 Jul 2009
Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.
Related pages in Patient UK
Your Experience (^ top of page)
Please add your experience about this condition / medicineMedical reference articles in PatientPlus related to this topic (^ top of page)
Drugs Used in Urinary RetentionMedicines related to this topic (^ top of page)
Cyproterone
FinasterideOther - Useful resources (^ top of page)
Pictures, diagrams, photos, images, etc.Evidence based medicine
Online textbooks and journals
A-Z of UK Guidelines
A-Z of Online Videos
Medline
Other good health sites
*** NEW *** Patient UK Newspaper
View current health newsMedical equipment products related to this topic (^ top of page)
Pill/Tablet Equipment
Books related to this topic (^ top of page)


Would you like to try our advanced on-line knowledge support system designed to provide professionals with relevant up to date information about recognition and management of disease or take the Mentor Challenge?
Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

